BenefitsPRO2d
New allergy drug uses $25 copay coupons to drive early sales
The maker of a new prescription drug product for people with life-threatening allergies is using copayment coupons to build ...
Drug Store News1d
Hikma launches cisatracurium besylate, gets OK for Kloxxado in Canada
Cisatracurium besylate injection has a market value of approximately $14 million in the 12 months ending January 2025, per ...
Onlymyhealth13d
Struggling with Nasal Congestion? Learn the Right Way to Use a Nasal Spray for Relief
Struggling with nasal congestion Learn the right way to use a nasal spray for quick relief Follow expert tips to avoid common ...
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...
Hikma Pharmaceuticals announces Health Canada approval of KLOXXADO nasal spray
Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...
Fierce Pharma6d
Paratek acquires Optinose, rhinosinusitis spray Xhance in deal worth up to $330M
In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals has bought out Optinose and its chronic ...
Pharmabiz3d
Health Canada approves Hikma Pharma’s Kloxxado nasal spray 8 mg for treatment of known or suspected opioid overdose
Health Canada approves Hikma Pharma’s Kloxxado nasal spray 8 mg for treatment of known or suspected opioid overdose: London Monday, March 24, 2025, 13:00 Hrs [IST] Hikma Pharmac ...